Rinedif 300mg treatment for infections, pneumonia, bronchitis (3 blisters x 10 tablets)

Dosage form Box of 3 blisters x 10 tablets
Specifications Cefdinir

Ingredient

Thành phần cho 1 viên

Composition informationContent
Cefdinir300mg

Uses

Indications

Rinedif drugs are indicated for treatment of mild to medium infections due to sensitive bacterial strains causing the following diseases:

Adults and teenagers (from 13 years old)

Pneumonia with the community caused by Haemophilus Influenzae (including β-lactamase strains), Haemophilus parainfluenzae (including β-lactamase strains), Streptococcus pneumoniae (indicating strains sensitive to penicilin), and Moraxella Catatrhalis (including seminarians. β-lactamase).

The acute drama of chronic bronchitis caused by Haemophilus Influenzae (including β-lactamase strains), Haemophilus parainfluenzae (including β-lactamase strains), Streptococcus pneumoniae (sensitive to penicilin), and Moraxella Catatrhalis (including seminarians. β-lactamase).

Hampled sinusitis caused by Haemophilus influenzae (including β-lactamase strains), Streptococcus pneumoniae (indicating strains sensitive to penicillin) and Moraxella Catarrhalis (including β-lactamase strains).

Sore throat/tonsillitis caused by Streptococcus pyogenes.

Note: Cefdinir is effective in killing S. Pyogenes from the palate. However, Cefdinir has not been studied to prevent rheumatoid fever after sore throat/tonsillitis caused by S.Pyogenes. Only intramuscular penicillin has been shown to prevent rheumatism.

Skin and uncomplicated skin and skin infections caused by Staphylococcus aureus (including β-lactamase strains) and Streptococcus pyogenes.

Pharmacological

No data.

pharmacokinetics

No data.

Before taking Rinedif 300mg treatment for infections, pneumonia, bronchitis (3 blisters x 10 tablets)

How to use

oral medication. Can take medicine when full or hungry.

Dosage

recommended doses and the time to treat bacterial infections in adults and adolescents described in the following table, the total daily dose for all bacterial infections is 600 mg/day (2 tablets/day).

Take the dose 1 time/day for 10 days as effective as the dose 2 times/day. Dosage 1 time/day has not been studied in pneumonia or skin infections, so it should be used 2 times/day in these infections.

adults and teenagers (13 years old)

Pneumonia has a community: taking a dose of 300 mg every 12 hours in 10 days.

The acute drama of chronic bronchitis: taking a dose of 300 mg every 12 hours in 5 - 10 days or 600 mg every 24 hours in 10 days.

Sinusitis above level: take a dose of 300 mg every 12 hours in 10 days or 600 mg every 24 hours in 10 days.

Sore throat/tonsillitis: take a dose of 300 mg every 12 hours in 5 - 10 days or 600 mg every 24 hours in 10 days.

Skin infections and uncomplicated skin structure: Use 300 mg every 12 hours in 10 days.

Patients with renal failure

For patients who are adults with creatinine clearance

Difficult to measure creatinine clearance in outpatient patients. However, the following formula can be used to predict creatinine clearance (CLCR) in adults. To predict valuable, serum creatinine level should reflect the level of stability of kidney function.

  • Male: Clcr = (Weight)*(140 - Age)/(72)*(Creatinin serum).
  • Women: Clcr = 0.85 x The above value.

    Patients who are getting hemorrhage

    Hemorrhage can be removed from the body. In patients maintaining regular hemorrhage, the recommended starting dose regimen is 300 mg or 7 mg/kg per day. At the end of each appraisal, it is advisable to use 300 mg (or 7 mg/kg). The next doses later (300 mg or 7 mg/kg) are used every day.

    Note: The above dose is for reference only. Specific dosage depends on the condition and level of progression of the disease. For a suitable dose, you need to consult a doctor or medical specialist.What to do when using overdose?

    What to do when you forget 1 dose? However, if the time to relax with the next dose is too short, skip the dose and continue the calendar of the drug. Do not use double dose to compensate for missed dose.

    • Side Effects

    Notify the physician the unwanted effects when using the drug.

    Warnings

    Before using the drug you need to read the instructions carefully and refer to the information below.

    contraindicated

    anti -contraindications in the following cases:

  • for patients with hypersensitivity to antibiotics Cephalosporin and penicillin, or with any ingredients in the pill.

    • Caution when using

    Warning:

    Before starting treatment with cefdinir, measures should be taken to determine whether patients have allergic reactions to cefdinir, other cephalosporins, penicilin, or other drugs. If using cefdinir with patients sensitive to penicillin, should be cautious by the cross-reaction between ß-lactam antibiotics that have documents and may occur up to 10% for patients with a history of allergies to penicillin. If the allergic reaction occurs with CEFDinir, the drug must be stopped. Serious hypersensitivity reactions can be treated with epinephrin and other emergency measures, including oxygen, solution intravenous, antihistamine, corticosteroid, respiratory control as a clinical indicator.

    Palmic colitis has been reported with almost all antibacterial agents, including CEFDinir, and may be seriously serious from mild to life -threatening.

    Therefore, it is important to consider this diagnosis in patients with diarrhea after taking antibacterial drugs.

    Treatment with antibacterial agents changes the normal bacterial system of the colon and may allow the excessive growth of Clostridia. Studies show that a poison produced by Clostridium difficile is a major cause of "colitis related to antibiotics."

    After the diagnosis is sure to have fake colitis, it is necessary to establish appropriate treatment measures. Mild cases of fake colitis often respond to drug stopping. In case of average to severe, it is advisable to consider the use of additional therapies for liquids and electrolytes, protein supplements and antibacterial treatments with clinical effect against Clostridium difficile.

    Caution:

    appointed cefdinir when not significantly infected or prescribed in case is not beneficial for patients and increases the risk of developing resistance bacteria.

    As other broad spectrum antibiotics, prolonged treatment can lead to excessive appearance and growth of resistance bacteria. Need to monitor patients carefully. If the superinfection occurs during treatment, it is recommended to use appropriate alternative therapy.

    As other broad -spectrum antibiotics, CEFDINIR indications for individuals with a history of bowel inflammation.

    In patients with transient or prolonged kidney failure (creatinine clearance

    The effect of drugs on driving and operating machinery

    has not been recorded on any effect.

    Use drugs for women during pregnancy and lactation

    Pregnant women

    cefdinir does not cause teratogenic rats when taking a dose of up to 1000 mg/kg/day (70 times the dose for people when calculating on mg/kg/day, 11 times higher when calculating on mg/m2/day) or in rabbits when using a dose of up to 10 mg/kg/day (0.7 times the dose for humans when calculating on mg/kg/day, 0.23 times higher when calculating on mg/m2/day).

    Mother's toxicity (weight reduction) is observed on rabbits with a maximum tolerance of 10 mg/kg/day without causing adverse effects for the child. The weight decreases in the mouse fetus at a dose of ≥ 100 mg/kg/day, and in the mouse with a dose of ≥ 32 mg/kg/day. No observation is effective on the parameters of the mother or reproductive, activity, development or survival function.

    However, there is no adequate and well -controlled research on pregnant women. Because reproductive studies on animals cannot help predict the response in humans, this drug should only be used during pregnancy when really necessary.

    breastfeeding

    After using a single dose of 600 mg, there is no cefdinir in breast milk.

    Drug interaction

    No data.

    Storage

    In a dry place, the temperature does not exceed 30 degrees Celsius, avoiding light.

    Other drugs

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    count views

    Popular Keywords